Deals
Lycia Therapeutics Files For Nasdaq IPO With No Revenue In 2026 After Eli Lilly Ended Its Deal
The filing reports a $19.2 million first-half loss, and it leaves the share count, price range and offering size blank.
Deals
The filing reports a $19.2 million first-half loss, and it leaves the share count, price range and offering size blank.
Deals
The board unanimously backs a Delaware parent that would own all of Donlin Gold, with Paulson's voting stake capped at 19.99%.
Deals
CEO and Chairman Junkoo Kim keeps both roles while the board pays $567,009 to cover his move and rewrites his exit terms.
Deals
The deal is targeted to close in Champion's fourth quarter of fiscal 2027, and every Timberline employee will be offered a job.
Deals
The 8-K does not state a price for the Microfluidics sale, the second unit Standard BioTools has moved to sell.
Deals
Former Qorvo holders will own about 37% of the combined company, and Skyworks expects $500 million or more in annualized savings.
Deals
The cash-and-stock deal offers RXO holders $30.25 a share implied, and closing is targeted for the first half of 2027.
Deals
An 8-K and investor slides show the take-private debt would push net leverage above the company's 3.5 to 4.0 times long-term target.
Deals
The pipe maker plans to pay with cash and its credit line, and expects the deal to add to adjusted earnings per share in year one.
Deals
An 8-K filed Friday shows Pinterest's board expanded bonus payouts and change-in-control protections for Level 21 employees, effective Wednesday.
Deals
ESCO paid $922 million in cash plus 5.10 million shares to acquire Megger from TBG AG on Thursday, drawing about $1.0 billion across three new credit facilities.
Deals
A competing offer that Synaptics' board briefly deemed superior forced onsemi to restructure its merger, slashing the total price by roughly $1.3 billion.